The Central Drugs Standard Control Organisation (CDSCO) has informed the World Health Organisation (WHO) that three cough syrups β Coldrif, Respifresh TR, and ReLife β have been recalled and their production has been stopped. The regulator has also clarified that none of these products were exported from India, as per a report by news agency PTI.
advertisement
The WHO had reached out to Indian authorities after media reports from Madhya Pradesh and Rajasthan described clusters of
Continue Reading on India Today
This preview shows approximately 15% of the article. Read the full story on the publisher's website to support quality journalism.